Skip Navigation


Hum. Reprod. Advance Access originally published online on October 24, 2006
Human Reproduction 2007 22(2):500-505; doi:10.1093/humrep/del416
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrowOA All Versions of this Article:
22/2/500    most recent
del416v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Google Scholar
Right arrow Articles by Crosignani, P.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crosignani, P.G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org

Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial

P.G. Crosignani1,3, E. Somigliana2,* on behalf of the Intrauterine Insemination (IUI) Study Group

1 Università degli Studi di Milano and 2 Infertility Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy

3 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology II, Università degli Studi di Milano, Via Commenda 12-20122, Milano, Italy. E-mail: piergiorgio.crosignani{at}unimi.it

BACKGROUND: The usefulness of GnRH antagonists in mild controlled ovarian hyperstimulation (COH) and intrauterine insemination (IUI) cycles is debated. METHODS: Two-hundred and ninety-nine couples with unexplained or mild male factor infertility were enrolled in this international multicentre randomized controlled trial. Women allocated to the GnRH antagonist group (n = 148) received 50 IU recombinant FSH starting on day 3 of the menstrual cycle and Ganirelix 0.25 mg daily starting from the day in which a follicle with a mean diameter of 13–14 mm was visualized at ultrasound. Women allocated to the control group (n = 151) were administered only 50 IU recombinant FSH starting on day 3 of the menstrual cycle. Couples were recruited only for their first treatment cycle. The primary outcome was the clinical pregnancy rate per initiated cycle. RESULTS: Baseline characteristics of the two treatment groups were similar. Clinical pregnancy rates per initiated cycle in women who did and did not receive GnRH antagonists were 12.2 and 12.6%, respectively (P = 1.00). The relative risk of conception (95% confidence interval) for the use of GnRH antagonists was 1.0 (0.5–1.9). CONCLUSIONS: In mild COH and IUI cycles, any benefit of the use of GnRH antagonists in improving pregnancy rates is <2-fold increase.

Key words: intrauterine insemination/mild ovarian hyperstimulation/GnRH antagonist

* M.A.Aboulghar, The Egyptian IVF-ET Center, Cairo, Egypt; A.Allegra, Reproductive Medicine Unit, ANDROS Day Surgery, Palermo, Italy; R.Buxaderas, Reproductive Medicine Service, Institut Universitari Dexeus, Barcelona, Spain; V.Forgacs, Forgacs Institute of Assisted Reproduction, Budapest, Hungary; G.Griesinger, Department of Obstetrics-Gynaecology, University Clinic of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany; R.Homburg, Division of Reproductive Medicine, Vrije Universiteit Medical Center, Amsterdam, The Netherlands; M.Hrehorcak, Center of Reproductive Medicine and Reproductive Genetics, 2nd Medical Faculty, Charles University, Prague, Czech Republic; J.Konc, Infertility and IVF Center of Buda, St. John’s Hospital, Budapest, Hungary; L.Mamas, Neogenesis, IVF Center, Athens, Greece; G.Ragni, Infertility Unit, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy; V.Silhan, Center of Assisted Reproduction SANUS, Hradec Kralove, Czech Republic.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Intrauterine insemination
Hum. Reprod. Update, May 1, 2009; 15(3): 265 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
M.M.E. van Rumste, I.M. Custers, F. van der Veen, M. van Wely, J.L.H. Evers, and B.W.J. Mol
The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis
Hum. Reprod. Update, November 1, 2008; 14(6): 563 - 570.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. N. Mahajan, K. N. Mahajan, and R. N. Soni
Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial
Hum. Reprod., October 1, 2007; 22(10): 2795 - 2795.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
P. G. Crosignani and E. Somigliana
Reply: Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial
Hum. Reprod., October 1, 2007; 22(10): 2796 - 2796.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.